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 Preface 
 
 
tance of topical therapies in IBD cannot be highlighted 
enough. Questions on fertility, outcome of pregnancy 
and breastfeeding in IBD are raised frequently by our pa-
tients.
 In this special issue of  Digestion these important topics 
are discussed in a very comprehensive way. Efforts have 
been undertaken to present many of the facts in a novel 
way. For example, we present for the first time a table with 
all rectally administered therapies with the respective 
volume of the preparation. It is surprising that this infor-
mation has not been available so far. For our patients with 
active colitis the volume of their rectal therapy definitely 
matters a lot and may decide on adherence and subse-
quently therapeutic success. To gather this information 
contacts with IBD centers and pharmacies all over Eu-
rope and Nothern America were necessary. This is just 
one example of the quality of information we aim to pro-
vide with this special edition of  Digestion .
 We definitely hope that this information will be help-
ful for both readers and later on for patients.
 Gerhard Rogler , Zürich
 Stephan Vavricka , Zürich
 Guest Editors
 
 Many reviews on the treatment of inflammatory bow-
el disease (IBD) have been published in recent years. So 
why add another special edition of  Digestion on this top-
ic to the list of publications on IBD treatment?
 First, views may differ in different areas of the world 
due to differences in resources and health systems. The 
articles published in this special edition of  Digestion re-
flect mainly the European view. Further, significant 
treatment progress has been made. New insights have 
been gained during the last years and treatment optimi-
zation has been studied in many trials. It is important to 
keep updated with these new insights to provide the best 
treatment possible for our patients.
 With calprotectin having an increasing role, the mon-
itoring of therapy has changed significantly. Therapy of 
steroid-resistant IBD is still a challenge and worth to be 
updated. The same is true for fibrostenotic and fistulizing 
Crohn’s disease. Mucosal healing under anti-TNF thera-
py is widely discussed and subsequently it appears to be 
important to bring the facts together in a comprehensive 
way. Extraintestinal manifestations are a frequent prob-
lem in our patients. However, it is not easy to find a com-
prehensive summary of possible treatments. The impor-
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